Back to top
more

Embecta Corp. (EMBC)

(Delayed Data from NSDQ)

$14.16 USD

14.16
2,583,790

+3.89 (37.88%)

Updated May 9, 2024 04:00 PM ET

After-Market: $14.20 +0.04 (0.28%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 250)

Industry: Medical Services

Better trading starts here.

Zacks News

Cencora (COR) Q2 Earnings Top Estimates

Cencora (COR) delivered earnings and revenue surprises of 4.11% and 2.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Best Value Stocks to Buy for February 12th

XRX, EMBC and HMN made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 12, 2023.

Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates

Embecta Corp. (EMBC) delivered earnings and revenue surprises of 35.56% and 4.15%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Premier, Inc. (PINC) Q2 Earnings Surpass Estimates

Premier, Inc. (PINC) delivered earnings and revenue surprises of 11.11% and 1.12%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Alignment Healthcare (ALHC) Moves 13.2% Higher: Will This Strength Last?

Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?

Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Investment Ideas feature highlights: Beacon Roofing Supply, Embecta and Western Midstream Partners

Beacon Roofing Supply, Embecta and Western Midstream Partners have been highlighted in this Investment Ideas article.

Shaun Pruitt headshot

Time to Buy These Intriguing Additions to Zacks Rank #1 (Strong Buy) List

Several intriguing stocks were recently added to the Zacks Rank #1 (Strong Buy) list this week and shouldn't be overlooked as we round out what has been an exciting year for the stock market.

Embecta Corp. (EMBC) Beats Q4 Earnings and Revenue Estimates

Embecta Corp. (EMBC) delivered earnings and revenue surprises of 40.48% and 1.75%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

IceCure Medical Ltd. (ICCM) Reports Q3 Loss, Misses Revenue Estimates

IceCure Medical Ltd. (ICCM) delivered earnings and revenue surprises of 0% and 65.58%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Embecta Corp. (EMBC) Q4 Earnings Expected to Decline

Embecta Corp. (EMBC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Lags Revenue Estimates

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -55.56% and 5.71%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for October 16th

CURO, ELUXY and EMBC have been added to the Zacks Rank #5 (Strong Sell) List on October 16, 2023.

Embecta Corp. (EMBC) Beats Q3 Earnings and Revenue Estimates

Embecta Corp. (EMBC) delivered earnings and revenue surprises of 50% and 4.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Avantor, Inc. (AVTR) Soars 6.7%: Is Further Upside Left in the Stock?

Avantor, Inc. (AVTR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for Investors

Good things could be on the horizon when a stock surpasses the 200-day simple moving average. How should investors react?

Embecta Corp. (EMBC) Recently Broke Out Above the 50-Day Moving Average

Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?

Company News for May 15, 2023

Companies in The News Are: IAG, SLF, NWSA, EMBC.

Embecta Corp. (EMBC) Dips More Than Broader Markets: What You Should Know

Embecta Corp. (EMBC) closed the most recent trading day at $28.52, moving -1.82% from the previous trading session.

Embecta (EMBC) to Report Q2 Earnings: What's in Store?

Embecta's (EMBC) diabetes care business is expected to have progressed in the fiscal second quarter banking on strong execution of its three strategic pillars.

Embecta Corp. (EMBC) Dips More Than Broader Markets: What You Should Know

Embecta Corp. (EMBC) closed at $27.36 in the latest trading session, marking a -1.12% move from the prior day.

Embecta Corp. (EMBC) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Embecta Corp. (EMBC) closed at $29.46, marking a +0.58% move from the previous day.

Here's Why You Should Retain Centene (CNC) in Your Portfolio

Strong membership growth, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Here's Why You Should Retain McKesson (MCK) Stock for Now

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.